Waters Stock Price, News & Analysis

Waters Corporation (NYSE:WAT) announced that CEO Udit Batra will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4th, 2025, at 8:45AM Eastern Time. The event will be webcast live on Waters' Investor Relations website, with a replay available for 90 days.

Waters Corporation is a global leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences. With over 65 years of experience and 7,600+ employees across 100+ countries, the company collaborates with customers in laboratories, manufacturing sites, and hospitals to advance scientific innovation.

Waters Corporation (NYSE:WAT) has integrated Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments from its Wyatt Technology Portfolio with Empower Software. This integration enables biologics data acquisition and quality control analysis, providing significant benefits: • Reduces software validation time by up to 6 months • Cuts analysis time for biotherapeutic peptides and proteins by 20% • Enhances quality control through absolute molecular weight measurements The integration includes DAWN, miniDAWN, and OptiLab Detectors and will be available in July 2025. Empower Software, used in over 80% of novel drug submissions to regulators, now offers improved efficiency and GMP readiness while reducing end-user training requirements in compliant settings.

Waters Corporation reported strong Q1 2025 financial results with sales of $662 million, up 4% as reported and 7% in constant currency. The company saw impressive instrument growth of 11% in constant currency, driven by pharmaceutical and industrial markets. GAAP EPS reached $2.03, while non-GAAP EPS was $2.25, showing 2% growth despite forex headwinds. Given the strong performance, Waters raised its full-year 2025 guidance, projecting constant currency sales growth of 5-7% and non-GAAP EPS of $12.75-$13.05. For Q2 2025, the company expects constant currency sales growth of 5-7% and non-GAAP EPS between $2.88-$2.98.

Waters (NYSE:WAT) has announced its upcoming first quarter 2025 earnings conference call, scheduled for Tuesday, May 6th, 2025 at 8:00 a.m. Eastern Time. The presentation will be accessible through a live webcast on the company's Investor Relations website, with replay availability until June 3rd, 2025.

Waters is a global leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences. The company employs 7,600 people across 100+ countries, working with customers in laboratories, manufacturing sites, and hospitals to advance scientific benefits.

Waters (NYSE:WAT) has expanded its Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection, enhancing capabilities for biopharmaceutical development and Quality Control laboratories. The system delivers significant improvements including:

• Up to 80x boost in sensitivity with MaxPeak™ Premier columns
• Over 3x improvement in day-to-day reproducibility
• Reduction in carryover by up to two orders of magnitude
• 40% reduction in common user errors

The platform is designed to simplify laboratory workflows and reduce out-of-specification results. All configurations are controlled by Waters Empower™ Chromatography Data System and support LIMS connectivity. The system has earned ACT Ecolabels from My Green Lab for sustainable manufacturing practices.

Waters (NYSE: WAT) has announced its participation in the upcoming Leerink Partners Global Healthcare Conference. CEO Udit Batra Ph.D. will engage in a fireside chat on Tuesday, March 11th, 2025 at 10:00AM Eastern Time.

The event will be accessible through a live webcast on Waters' Investor Relations website, with replay available for 90 days. Waters , with a 65-year legacy, operates globally as a leader in analytical instruments, separations technologies, and software for life, materials, food, and environmental sciences.

• Global presence in over 100 countries
• 7,600 employees worldwide
• Focus on medicine efficacy, food safety, water purity, and product quality
• Collaborates with laboratories, manufacturing sites, and hospitals

Waters (NYSE: WAT) reported strong Q4 2024 results with sales of $873 million, up 6% as reported and 8% in constant currency. Q4 highlights include 8% instrument growth and 9% recurring revenue growth in constant currency. Pharmaceutical sector showed robust performance, growing 10% in constant currency.

Full-year 2024 sales reached $2,958 million, flat year-over-year. The company achieved GAAP EPS of $10.71 and non-GAAP EPS of $11.86, up 1% from 2023 despite 5% foreign exchange headwinds. Waters generated strong cash flow with $762 million in operating cash flow and $744 million in free cash flow.

Looking ahead to 2025, Waters projects constant currency sales growth of 4.5% to 7.0%, with reported growth between 2.5% to 5.0% after accounting for currency impact. The company expects 2025 non-GAAP EPS between $12.70 and $13.00, facing approximately 4% headwind from foreign exchange.

Waters (NYSE:WAT) has launched the TA Instruments™ ElectroForce™ Apex 1 Mechanical Testing Instrument, designed for testing high-performance polymers and composites. The instrument offers 43% greater motor stroke range (100 mm) than competitors and can complete fatigue testing up to 30% faster, enhancing product development efficiency.

The system features automated controls and TuneIQ™ Technology for automatic instrument tuning without operator intervention. It includes improved break-stop capabilities and intelligent data acquisition to prevent computer overload. The instrument targets industries including medical device, polymer, aerospace, automotive, and additive manufacturing, where material strength and durability testing is crucial.

Waters (NYSE:WAT) has launched TGA Smart-Seal™ Pans from its TA Instruments Division, a new proprietary product for analyzing atmosphere-sensitive materials in benchtop thermogravimetric analyzers (TGA). The innovative self-opening sample container reduces TGA system costs and footprint by up to 50% by eliminating the need for environment-controlled housing or gloveboxes.

The Smart-Seal Pans feature a proprietary temperature-sensitive shape memory alloy that automatically opens at around 55°C, allowing air-sensitive materials to be prepared and sealed in an airtight environment. The technology enables analysis of materials used in battery development, advanced polymers, and medicines without exposure to ambient conditions.

The solution increases laboratory throughput while maintaining data quality, allows preparation of multiple samples simultaneously, and eliminates the need for costly gloveboxes that typically double TGA setup costs. The product is now available globally.